Sandra Boboso
Health economist at the Information Technology and Innovation Foundation who discusses the economic costs of obesity and the potential impact of GLP-1 drugs on healthcare spending and productivity.
Best podcasts with Sandra Boboso
Ranked by the Snipd community
Mar 4, 2026 • 17min
Are weight-loss drugs reshaping business?
Sandra Boboso, a health economist who studies obesity costs and drug impacts, and Gabe Zickerman, founder of protein, no-added-sugar ice cream Two Scoops. They discuss how GLP-1 drugs widened consumer demand, how food and fitness businesses are adapting, shifting shopping habits and spending, and the likely future of prices, access and market opportunities.
